PDBsum entry 1vcu

Go to PDB code: 
Top Page protein ligands Protein-protein interface(s) links
Hydrolase PDB id
Protein chain
370 a.a.
DAN ×2
EPE ×4
Waters ×131

References listed in PDB file
Key reference
Title Crystal structure of the human cytosolic sialidase neu2. Evidence for the dynamic nature of substrate recognition.
Authors L.M.Chavas, C.Tringali, P.Fusi, B.Venerando, G.Tettamanti, R.Kato, E.Monti, S.Wakatsuki.
Ref. J Biol Chem, 2005, 280, 469-475. [DOI no: 10.1074/jbc.M411506200]
PubMed id 15501818
Gangliosides play key roles in cell differentiation, cell-cell interactions, and transmembrane signaling. Sialidases hydrolyze sialic acids to produce asialo compounds, which is the first step of degradation processes of glycoproteins and gangliosides. Sialidase involvement has been implicated in some lysosomal storage disorders such as sialidosis and galactosialidosis. Neu2 is a recently identified human cytosolic sialidase. Here we report the first high resolution x-ray structures of mammalian sialidase, human Neu2, in its apo form and in complex with an inhibitor, 2-deoxy-2,3-dehydro-N-acetylneuraminic acid (DANA). The structure shows the canonical six-blade beta-propeller observed in viral and bacterial sialidases with its active site in a shallow crevice. In the complex structure, the inhibitor lies in the catalytic crevice surrounded by ten amino acids. In particular, the arginine triad, conserved among sialidases, aids in the proper positioning of the carboxylate group of DANA within the active site region. The tyrosine residue, Tyr(334), conserved among mammalian and bacterial sialidases as well as in viral neuraminidases, facilitates the enzymatic reaction by stabilizing a putative carbonium ion in the transition state. The loops containing Glu(111) and the catalytic aspartate Asp(46) are disordered in the apo form but upon binding of DANA become ordered to adopt two short alpha-helices to cover the inhibitor, illustrating the dynamic nature of substrate recognition. The N-acetyl and glycerol moieties of DANA are recognized by Neu2 residues not shared by bacterial sialidases and viral neuraminidases, which can be regarded as a key structural difference for potential drug design against bacteria, influenza, and other viruses.
Figure 1.
FIG. 1. Sialic acid and inhibitors. Schematic structure of a sialylgalactose (a), NANA (b), and DANA (c). In the case of the sialylgalactose, the dotted line indicates the bond hydrolyzed by the sialidase.
Figure 4.
FIG. 4. Structural changes of Neu2 upon maltose and DANA binding. a, ribbon diagram of Neu2 apo form, viewed from the side. The active site is located on the top part of the protein. Secondary elements are colored as in Fig. 2. b, Neu2 sugar-induced form in the same orientation as in a. The arrow indicates the loop containing Glu111 that becomes ordered and forms helix 2. c, Neu2-DANA complex in the same orientation as in a. DANA is represented as a ball-and-stick model. The arrows indicate two helices ( 1 and 2) that are formed upon inhibitor binding.
The above figures are reprinted by permission from the ASBMB: J Biol Chem (2005, 280, 469-475) copyright 2005.
Go to PROCHECK summary